Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cancer Pain × Ketamine × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 3 Pain 3 Neoplasms 3 Agnosia 3 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain, Procedural 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

Pharmaceutical Services 2 Lidocaine 2 Ethanol 2 Acetaminophen 2 Venlafaxine Hydrochloride 1 Telemedicine 1 Ropivacaine 1 Radiofrequency Ablation 1 Pregabalin 1 Oxycodone 1 Morphine 1 Methadone 1 Memantine 1 Ketamine 1 Hospitals 1 Gels 1 Cholecalciferol 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03362073 2021-09-28

CIVIK

Pusan National University Yangsan Hospital

Phase 2 Unknown

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡